NCM·Healthcare·$80M·#88 / 520 in Healthcare
SCLX Scilex Holding Company
66SOLID
CATEGORY BREAKDOWN
GROWTH0
QUALITY55
STABILITY100
VALUATION92
GOVERNANCE84
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-46.5%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
65.0%
92
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-59.7%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.6x
92
< 3x strong
Rule of 40
Growth rate plus operating margin
-947
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
17.6%
80
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.2%
93
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SCLX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SCLX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.